Chhitar Mal Gupta (born 1944) is an Indian molecular biologist and academic, known for researches on transbilayer phospholipid asymmetry in biological membranes.,[1] drug targeting in parasitic diseases and characterization of structure and function of Leishmania actin and actin binding proteins.
[3] Gupta graduated in medicinal chemistry from the Central Drug Research Institute, Lucknow, India with the degrees MSc and PhD.
[2] He has extensively contributed in the areas of drug targeting in parasitic diseases and membrane phospholipids transbilayer dynamics, and is working on elucidation of actin cytoskeletal network in Leishmania.
These studies have resulted in publication of about 136 original research papers, 10 review articles, 5 book chapters and 6 patents.
He along with CDRI scientists have been accused of attempted fraud bid for a clinical isolates that was published in an International journal.